120 related articles for article (PubMed ID: 36453189)
1. Prediction of high-risk factors for ovarian metastasis in patients with endometrial cancer: A large-sample retrospective case-control study.
Li Q; Zhang X
Int J Gynaecol Obstet; 2023 Apr; 161(1):144-150. PubMed ID: 36453189
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
[TBL] [Abstract][Full Text] [Related]
3. Ovarian preservation in young women with endometrial cancer of endometrioid histology.
Kinjyo Y; Kudaka W; Ooyama T; Inamine M; Nagai Y; Aoki Y
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):430-4. PubMed ID: 25603833
[TBL] [Abstract][Full Text] [Related]
4. Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival.
Ignatov T; Eggemann H; Burger E; Ortmann O; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1103-1107. PubMed ID: 29541859
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
[TBL] [Abstract][Full Text] [Related]
6. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.
Wang Y; Han C; Teng F; Bai Z; Tian W; Xue F
Int J Gynaecol Obstet; 2017 Jan; 136(1):58-63. PubMed ID: 28099710
[TBL] [Abstract][Full Text] [Related]
8. Ovarian metastasis in endometrial carcinoma.
Takeshima N; Hirai Y; Yano K; Tanaka N; Yamauchi K; Hasumi K
Gynecol Oncol; 1998 Aug; 70(2):183-7. PubMed ID: 9740687
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
10. Clinicopathologic variables and survival comparison of patients with synchronous endometrial and ovarian cancers versus primary endometrial cancer with ovarian metastasis.
Oranratanaphan S; Manchana T; Sirisabya N
Asian Pac J Cancer Prev; 2008; 9(3):403-7. PubMed ID: 18990010
[TBL] [Abstract][Full Text] [Related]
11. Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study.
Ling X; Zheng Z; Xu J; Xu G; Zhou H; Lin Z; Li Y; Liang J; Lu H
Med Sci Monit; 2020 Dec; 26():e928826. PubMed ID: 33361739
[TBL] [Abstract][Full Text] [Related]
12. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the risk factors for ovarian metastasis in patients with endometrial carcinoma].
Chai Y; Huang XF; Xie X; Lü WG; Ye DF; Chen HZ
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):162-4. PubMed ID: 15130374
[TBL] [Abstract][Full Text] [Related]
14. Ovarian metastasis risk factors in endometrial carcinoma: A systematic review and meta-analysis.
Liang X; Zeng H; Chen S; Jiang M; Liu S; Fan J
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():245-255. PubMed ID: 34837854
[TBL] [Abstract][Full Text] [Related]
15. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
[TBL] [Abstract][Full Text] [Related]
16. Ovarian involvement in endometrioid adenocarcinoma of uterus.
Lin KY; Miller DS; Bailey AA; Andrews SJ; Kehoe SM; Richardson DL; Lea JS
Gynecol Oncol; 2015 Sep; 138(3):532-5. PubMed ID: 26186908
[TBL] [Abstract][Full Text] [Related]
17. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
[TBL] [Abstract][Full Text] [Related]
18. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer.
Tang X; Tanemura K; Ye W; Ohmi K; Tsunematsu R; Yamada T; Katsumata N; Sonoda T
Jpn J Clin Oncol; 1998 Nov; 28(11):673-8. PubMed ID: 9861234
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and clinicopathological features of patients with ovarian metastasis of endometrial cancer: a retrospective study.
Matoba Y; Yamagami W; Chiyoda T; Kobayashi Y; Tominaga E; Banno K; Aoki D
J Obstet Gynaecol; 2022 Aug; 42(6):2456-2462. PubMed ID: 35653769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
